Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-23-005996

CFO & COO sold 3,596 shares at $3.92 ($14,096)

From the SEC's structured data for this filing

Trades in this filing

GRAY MICHAEL · CFO & COO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-30 Sale : show line 1 in the form −3,596 $3.92 $14,096 37,466 D
Open-market sales · 3,596 sh · avg $3.92 · $14,096
Loading xslF345X03/doc4.xml…